Business · 1 sources covering this

Ipca surges 11% in tepid market, nears 52-week high on healthy Q1 results

Ipca Laboratories upgraded FY27 revenue growth guidance to 14-16 per cent from 12-13 per cent and raised consolidated EBITDA margin guidance to 23 per cent from 22 per cent.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Ipca surges 11% in tepid market, nears 52-week high on healthy Q1 results
Ipca Laboratories upgraded FY27 revenue growth guidance to 14-16 per cent from 12-13 per cent and raised consolidated EBITDA margin guidance to 23 per cent from 22 per cent.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/98d9dea531641f4af269a410566c9c50ff34f0d1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Ipca surges 11% in tepid market, nears 52-week high on healthy Q1 results"></iframe>

Ipca surges 11% in tepid market, nears 52-week high on healthy Q1 results

How 1 sources are covering this

Ipca surges 11% in tepid market, nears 52-week high on healthy Q1 results

More from Business

Price taker to price setter: India’s commodity derivatives market

Delhi Master Plan 2047: How housing, transport and land use may change

NRI life insurance: Buy in India or abroad?

India seaplanes get electrifying push

Reader

Trust & legal

Across the network